Fact‐finding survey on assisted reproductive technology in Japan
Journal of Obstetrics and Gynaecology Research · 2023
DOI: 10.1111/jog.15780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2023. Verfasst von Sayaka Harada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted, Fertilization in Vitro. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
In anticipation of the future development of assisted reproductive technology (ART) and to smoothly introduce new technology, it is necessary to understand the current staffing status of the medical system and the current state of treatment, as well as the status of in vitro fertilization add‐ons, where the need for insurance coverage is currently a matter of debate.
Methods
ART facilities in Japan were surveyed (437 valid responses, response rate: 71%). Current staffing status of the medical system, implementation rates of ART, add‐on treatments, and medical supplies were investigated.
Results
Despite the abundance of embryologists, nurses, and obstetricians and gynecologists in facilities, the majority of facilities lacked counselors, anesthesiologists, and other essential medical professionals. Conventional ovarian stimulation was widely adopted (median 120 [interquartile range 60–300] cycles), followed by mild ovarian simulation (60 [30–200]). Additionally, freeze–thaw embryo transfer cycles (300 [120–750]) were performed more frequently than fresh embryo transfer cycles (30 [30–60]). Among the add‐ons, assisted hatching (85.1%), chronic endometritis examination (77.2%) and treatment (76.9%), artificial oocyte activation (67.3%), endometrial receptivity analysis (64.2%), and endometrial microbiome analysis (58.9%) were relatively widely employed.
Conclusions
The implementation of frozen–thawed embryo transfer cycles, freeze‐all strategies, and add‐on treatments have become popular and widely accepted despite the lack of robust evidence regarding their safety and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
- Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine, Akita, Japan.
- Department of Obstetrics and Gynecology, Saitama Medical University, Saitama, Japan.
- Center for Reproductive Medicine and Endoscopy, Sugiyama Clinic Marunouchi, Tokyo, Japan.
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Mitsutoshi Yamada, Hiromitsu Shirasawa, Seung Chik Jwa, Keiji Kuroda, Miyuki Harada, Yutaka Osuga
Zitieren
APA
Harada, S., Yamada, M., Shirasawa, H., Jwa, S. C., Kuroda, K., Harada, M., & Osuga, Y. (2023). Fact‐finding survey on assisted reproductive technology in Japan. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15780
Vancouver
Harada S, Yamada M, Shirasawa H, Jwa SC, Kuroda K, Harada M, et al. Fact‐finding survey on assisted reproductive technology in Japan. Journal of Obstetrics and Gynaecology Research. 2023. doi:10.1111/jog.15780
BibTeX
@article{Harada2023,
author = {Harada, Sayaka and Yamada, Mitsutoshi and Shirasawa, Hiromitsu and Jwa, Seung Chik and Kuroda, Keiji and Harada, Miyuki and Osuga, Yutaka},
title = {Fact‐finding survey on assisted reproductive technology in Japan},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2023},
doi = {10.1111/jog.15780}
}
EUVIMED